Related Experiment Video

Updated: Feb 4, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.9K

[Expert consensus on the management process within medical institutions for patients with hepatitis B virus

    Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
    |February 2, 2026
    PubMed

    Insights

    This expert consensus provides guidelines for managing hepatitis B virus (HBV) infection in China. Its implementation aims to improve diagnosis and treatment rates, supporting the WHO's 2030 hepatitis elimination goal.

    Area of Science:

    • Hepatology
    • Public Health
    • Infectious Disease Management

    Background:

    • Hepatitis B virus (HBV) infection remains a significant public health concern.
    • Effective utilization of information from routine health checkups is crucial for HBV management.
    • Current management practices in Chinese medical institutions require standardized guidelines.

    Purpose of the Study:

    • To develop an expert consensus on the management process for HBV-infected patients within Chinese medical institutions.
    • To provide standardized guidelines for prevention, diagnosis, and treatment of HBV.
    • To align with the World Health Organization's 2030 goal for hepatitis elimination.

    Main Methods:

    • A panel of experts from clinical medicine, public health, laboratory testing, and methodology was convened.
    • A comprehensive review of the latest research findings and international guidelines for HBV prevention and treatment was conducted.
    • The consensus was formulated considering the specific situation of medical and health institutions in China.

    Main Results:

    • The consensus outlines standardized management processes for HBV-infected patients.
    • Key quality control indicators for HBV management are defined.
    • Recommendations for referral, diagnosis, and treatment protocols are provided.

    Conclusions:

    • The implementation of this expert consensus is expected to enhance the diagnosis and treatment rates of viral hepatitis B in China.
    • Standardized management will contribute to the effective control of HBV infection.
    • Achieving the WHO's 2030 goal of eliminating viral hepatitis as a public health threat is a primary objective.

    More Related Videos

    Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle09:35

    Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

    Published on: February 1, 2017

    14.0K
    A Protocol for Analyzing Hepatitis C Virus Replication13:04

    A Protocol for Analyzing Hepatitis C Virus Replication

    Published on: June 26, 2014

    24.7K

    Related Concept Videos

    Endocarditis III: Medical Management01:18

    Endocarditis III: Medical Management

    Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
    258
    Myocarditis III: Medical Management01:14

    Myocarditis III: Medical Management

    Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
    216
    Pericarditis III: Medical Management01:17

    Pericarditis III: Medical Management

    The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
    359
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    319
    Mitral Stenosis III: Medical Management01:26

    Mitral Stenosis III: Medical Management

    Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
    301
    Aortic Regurgitation III: Medical Management01:25

    Aortic Regurgitation III: Medical Management

    Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
    443